COVID-19-specific Prefectural Hospital Bed Utilization Rate and In-hospital Mortality Among COVID-19 Patients Throughout the First 3 Years of the Pandemic in Japan

日本新冠疫情爆发前三年各都道府县医院新冠肺炎相关病床使用率及新冠肺炎患者院内死亡率

阅读:3

Abstract

BACKGROUND: We examined the association between the coronavirus disease 2019 (COVID-19)-specific prefectural bed utilization rate and in-hospital mortality during the first 3 years of the pandemic in Japan. METHODS: This nationwide study included 58,175 COVID-19 patients from the COVID-19 Registry Japan, hospitalized between May 1, 2020 and November 30, 2022. Based on the weekly COVID-19-specific bed utilization rate in each prefecture at diagnosis, patients were categorized into four groups (<25%, 25% to <50%, 50% to <75%, and ≥75%). Odds ratios (ORs) were estimated by fitting a generalized linear mixed model with prefecture as a random intercept and adjusting for covariates (age, gender, body mass index, smoking and drinking status, and comorbidities). Additional analyses according to age group, gender, and wave of the pandemic were conducted. RESULTS: We observed 2,312 (4.0%) all-cause in-hospital deaths. All-cause in-hospital mortality increased with higher COVID-19 bed utilization rates at diagnosis (OR for multivariable model 1.35; 95% confidence interval [CI], 1.19-1.54 for 25% to <50%; OR 1.89; 95% CI, 1.66-2.16 for 50 to <75%; OR 2.16; 95% CI, 1.80-2.58 for ≥75%; P for trend <0.0001). Stronger associations were noted among the younger population (aged <70 years: OR 3.18; 95% CI, 1.96-5.19) and during the fourth (March 1-June 30, 2021: OR 3.81; 95% CI, 2.13-6.80) and sixth pandemic waves (January 1-June 30, 2022: OR 2.67; 95% CI, 1.68-4.23). CONCLUSION: Our results emphasize that preventing hospital bed shortages during outbreaks is an important public health strategy to reduce the associated mortality, particularly when new strains emerge and in younger people.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。